These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38521111)

  • 1. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin.
    Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y
    Gene; 2024 Jul; 914():148406. PubMed ID: 38521111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-200b-3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer.
    Wu YZ; Lin HY; Zhang Y; Chen WF
    J Gene Med; 2020 Jul; 22(7):e3178. PubMed ID: 32092782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
    Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
    Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
    Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
    Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K
    Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-hydroxybutyrate resensitizes colorectal cancer cells to oxaliplatin by suppressing H3K79 methylation in vitro and in vivo.
    Deng M; Yan P; Gong H; Li G; Wang J
    Mol Med; 2024 Jun; 30(1):95. PubMed ID: 38910244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Cyanidin-3-
    Kurter H; Basbinar Y; Ellidokuz H; Calibasi-Kocal G
    Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.
    Dong Y; Wang Z; Xie GF; Li C; Zuo WW; Meng G; Xu CP; Li JJ
    Mol Cancer; 2017 Mar; 16(1):71. PubMed ID: 28356150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-binding protein CELF1 enhances cell migration, invasion, and chemoresistance by targeting ETS2 in colorectal cancer.
    Wang H; Huang R; Guo W; Qin X; Yang Z; Yuan Z; Wei Y; Mo C; Zeng Z; Luo J; Cai J; Wang H
    Clin Sci (Lond); 2020 Jul; 134(14):1973-1990. PubMed ID: 32677671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of TMEM45A overcomes multidrug resistance and epithelial-mesenchymal transition in human colorectal cancer cells through inhibition of TGF-β signalling pathway.
    Zhu M; Jiang B; Yan D; Wang X; Ge H; Sun Y
    Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):503-516. PubMed ID: 31788833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A8 promotes epithelial-mesenchymal transition and metastasis under TGF-β/USF2 axis in colorectal cancer.
    Li S; Zhang J; Qian S; Wu X; Sun L; Ling T; Jin Y; Li W; Sun L; Lai M; Xu F
    Cancer Commun (Lond); 2021 Feb; 41(2):154-170. PubMed ID: 33389821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer.
    Xiao Z; Liu Y; Li Q; Liu Q; Liu Y; Luo Y; Wei S
    Cancer Chemother Pharmacol; 2021 Dec; 88(6):1021-1031. PubMed ID: 34599680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV Induced miR-134 Expression Reduces EMT and Increases Chemotherapeutic Sensitivity by Suppressing CREB1 Signaling in Colorectal Cancer Cell Line SW-480.
    Ye Q; Su L; Chen D; Zheng W; Liu Y
    Cell Physiol Biochem; 2017; 43(4):1617-1626. PubMed ID: 29041002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways.
    Duan L; Wu R; Zou Z; Wang H; Ye L; Li H; Yuan S; Li X; Zha H; Sun H; Zhang Y; Chen X; Zhou L
    Int J Oncol; 2014 Mar; 44(3):781-90. PubMed ID: 24378749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell lines.
    Skarkova V; Skarka A; Manethova M; Stefanidi AA; Rudolf E
    Hum Exp Toxicol; 2021 Dec; 40(12):2063-2073. PubMed ID: 34075792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway.
    Zhang Y; Sun L; Sun Y; Chen Y; Wang X; Xu M; Chi P; Xu Z; Lu X
    Exp Cell Res; 2020 Apr; 389(1):111856. PubMed ID: 31981591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 20. The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells.
    Shen X; Hu X; Mao J; Wu Y; Liu H; Shen J; Yu J; Chen W
    Cell Death Dis; 2020 Jan; 11(1):65. PubMed ID: 31988275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.